Dmk Pharmaceuticals (DMK) Inventory Turnover Ratio, from third quarter 2023 to third quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Dmk Pharmaceuticals Corporation  (NASDAQ: DMK)
 

Dmk Pharmaceuticals Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Dmk Pharmaceuticals's inventory turnover ratio, the ratio that measures Dmk Pharmaceuticals's ability to manage its supply chain, sequentially decreased to 6.04 in the third quarter 2023, which does not come as a surprise, as the Dmk Pharmaceuticals continue to experience headwinds, which also impact its supply chain. Dmk Pharmaceuticals's average inventory processing period in the Sep 30 2023 quarter, has increased to 60 days, from 54 days, in the Jun 30 2023 quarter.

Within Healthcare sector 63 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2023, to 494, from total ranking in the second quarter 2023 at 549.

DMK Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Dmk Pharmaceuticals Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DMK Inventory Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Inventory Growth -39.31 % 50.92 % 1976.25 % 195.93 % -
Y / Y Cost of Sales Growth -79.46 % -47.56 % 22.17 % 19.65 % 33.34 %
Inventory Turnover Ratio (TTM) 6.04 6.76 7.58 8.83 11.69
DMK's Total Ranking # 494 # 549 # 550 # 657 # 656
Average inventory processing period 60 54 48 41 31
Seq. Inventory Growth -0.21 % 0 % -46.37 % 13.39 % 148.17 %
Seq. Cost of Sales Growth -6.34 % -79.79 % -25.1 % 44.89 % 139.07 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 64
Overall Market # 494

Inventory Turnover Ratio Statistics
High Average Low
11.69 6.14 3.42
(Sep 30 2022)   (Sep 30 2018)



DMK Company Profile >> Back to DMK Efficiency Comparisons >> Compare DMK Inventory Turnover Ratio to its Competitors

Financial Statements
Dmk Pharmaceuticals's Inventories $ 1 Millions Visit DMK's Balance sheet
Dmk Pharmaceuticals's Cost of Revenues TTM $ 5 Millions Visit DMK's Income Statement
What are DMK's Sales? Visit DMK's Sales by Segment

Other Inventory Turnover Ratios
Dmk Pharmaceuticals's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
DMK's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for DMK's Competitors
Inventory Turnover Ratio for DMK's Suppliers
Inventory Turnover Ratio for DMK's Customers

You may also want to know
DMK's Sales Growth Rates DMK's Pe Price to earnings ratio DMK's Receivables Turnover Ratio DMK's Stock Quote
DMK's Net Income Growth Rates DMK's Ps Price to Sales ratio DMK's Sales per Employee DMK's Asset Turnover Ratio
DMK's Net Margin DMK's Pb Price to Book ratio DMK's Financial Strength Ratios DMK's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2023 Inventories at quarter ending Sep 30 2023
Intelgenx Technologies Corp   18.73 $ 1.386  Millions$ 0  Millions
Teladoc Health Inc   17.56 $ 755.480  Millions$ 43  Millions
Viemed Healthcare Inc   16.38 $ 66.209  Millions$ 4  Millions
Qhslab Inc   16.29 $ 0.623  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   16.03 $ 17.574  Millions$ 1  Millions
Bgm Group Ltd  15.45 $ 44.000  Millions$ 3  Millions
Invitae Corporation  15.28 $ 350.946  Millions$ 23  Millions
Precipio inc   14.27 $ 8.656  Millions$ 1  Millions
Wearable Health Solutions, Inc.  14.21 $ 0.408  Millions$ 0  Millions
Natera Inc   13.98 $ 562.090  Millions$ 40  Millions
Genedx Holdings Corp   13.87 $ 162.579  Millions$ 12  Millions
Option Care Health Inc   13.11 $ 3,239.218  Millions$ 247  Millions
Aspira Women s Health inc   13.06 $ 3.889  Millions$ 0  Millions
Agape Atp Corporation  12.72 $ 0.682  Millions$ 0  Millions
Agile Therapeutics Inc  12.70 $ 26.956  Millions$ 2  Millions
Rockwell Medical inc   12.68 $ 71.973  Millions$ 6  Millions
Lantheus Holdings Inc   12.00 $ 557.756  Millions$ 46  Millions
23andme Holding Co  11.97 $ 146.584  Millions$ 12  Millions
Eton Pharmaceuticals Inc   11.50 $ 8.227  Millions$ 1  Millions
Sotera Health Company  11.01 $ 450.957  Millions$ 41  Millions
Sunlink Health Systems Inc   10.91 $ 18.973  Millions$ 2  Millions
Infusystem Holdings Inc  10.52 $ 58.532  Millions$ 6  Millions
Myriad Genetics Inc   10.21 $ 228.500  Millions$ 22  Millions
Puma Biotechnology Inc   10.16 $ 55.195  Millions$ 5  Millions
Semler Scientific inc   10.08 $ 4.780  Millions$ 0  Millions
Irhythm Holdings Inc   9.97 $ 148.665  Millions$ 15  Millions
Cryo cell International Inc   9.21 $ 8.506  Millions$ 1  Millions
Novavax inc   9.04 $ 370.557  Millions$ 41  Millions
Dermtech Inc   8.96 $ 13.171  Millions$ 1  Millions
Bionexus Gene Lab Corp   8.57 $ 8.892  Millions$ 1  Millions

Date modified: 2026-08-29T17:18:55+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.